Contribution of renal scintigraphy to management of patients with acute renal allograft dysfunction.
Aktas
A
A
Baskent University Faculty of Medicine, Ankara, Turkey.
Moray
G
G
Karakayali
H
H
Bilgin
N
N
D000208:Acute Disease; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D015902:Gamma Cameras; D006084:Graft Rejection / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000000981:diagnostic imaging*; D016030:Kidney Transplantation / Q000473:pathology* / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D012189:Retrospective Studies; D016284:Technetium Tc 99m Pentetate
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D019275:Radiopharmaceuticals; D003404:Creatinine; D016284:Technetium Tc 99m Pentetate